Nymox PharmaceuticalNYMXF
13F holders, Q1 2024 (March 31)3holders
$0.40avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Nymox Pharmaceutical Corp. (NYMXF) in their 13F filings. The largest holders were DF Dent & Co. Inc. ($30K), First Citizens Financial Corp ($14K) and Cubic Asset Management, LLC ($4K).
- Company
- Nymox Pharmaceutical Corp.
- CUSIP
- P73398102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $30K |
| Exits | 0 | $0 |
Ownership 3 holders
| DF Dent & Co. Inc. | 0.00% | New | 75,000 | $30K |
| First Citizens Financial Corp | 0.01% | No change | 35,100 | $14K |
| Cubic Asset Management, LLC | 0.00% | No change | 10,000 | $4K |
"% of holder's portfolio" is NYMXF's weight in each manager's 13F, not the share of Nymox Pharmaceutical Corp. the manager owns.